Teresinha Leal

Modified method to measure nasal potential difference.

Vancomycin penetration of uninfected pleural fluid exudate after continuous or intermittent infusion.

The role of epithelial P2Y2 and P2Y4 receptors in the regulation of intestinal chloride secretion.

Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis.

Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice.

Cystic fibrosis is associated with a defect in apical receptor-mediated endocytosis in mouse and human kidney.

An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis.

Effect of continuous positive airway pressure combined to nebulization on lung deposition measured by urinary excretion of amikacin.

Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis.

Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis.

Airway ion transport impacts on disease presentation and severity in cystic fibrosis.

Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis.

Airway delivery of low-dose miglustat normalizes nasal potential difference in F508del cystic fibrosis mice.

Azithromycin fails to reduce increased expression of neutrophil-related cytokines in primary-cultured epithelial cells from cystic fibrosis mice.

Inhaled phosphodiesterase type 5 inhibitors restore chloride transport in cystic fibrosis mice.

Delivery efficacy of a vibrating mesh nebulizer and a jet nebulizer under different configurations.

Decreased renal accumulation of aminoglycoside reflects defective receptor-mediated endocytosis in cystic fibrosis and Dent's disease.

A randomized placebo-controlled trial of miglustat in cystic fibrosis based on nasal potential difference.

Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice.

Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.

PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis.

Dysregulated proinflammatory and fibrogenic phenotype of fibroblasts in cystic fibrosis.

Clinical and morphological characteristics of sporadic genetically determined pancreatitis as compared to idiopathic pancreatitis: higher risk of pancreatic cancer in CFTR variants.

Nasal potential difference measurements in diagnosis of cystic fibrosis: an international survey.

Correction of chloride transport and mislocalization of CFTR protein by vardenafil in the gastrointestinal tract of cystic fibrosis mice.

Lung inflammation in cystic fibrosis: pathogenesis and novel therapies.

Impact of MIF gene promoter polymorphism on F508del cystic fibrosis patients.

Resveratrol increases F508del-CFTR dependent salivary secretion in cystic fibrosis mice.

Identification and frequencies of cystic fibrosis mutations in central Argentina.

Mutations of Cystic Fibrosis Transmembrane Conductance Regulator Gene Cause a Monocyte-Selective Adhesion Deficiency.

Strategies in early clinical development for the treatment of basic defects of cystic fibrosis.

Influence of Tracheostomy on Lung Deposition in Spontaneously Breathing Patients.

HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients.

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives.

Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium.

Vardenafil reduces macrophage pro-inflammatory overresponses in cystic fibrosis through PDE5- and CFTR-dependent mechanisms.

Production and characterization of a PEGylated derivative of recombinant human deoxyribonuclease I for cystic fibrosis therapy.

In Vitro and In Vivo Evaluation of the Combination of Oscillating Positive Expiratory Pressure and Nebulization: A Randomized Cross-Over Study.

In Vitro and In Vivo Comparison of Two Nebulizers Used for Inhaled Pentamidine Delivery.

Ratiometric sweat secretion optical test in cystic fibrosis, carriers and healthy subjects.

Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum.